Micro-Leads Medical specializes in advanced neuromodulation technologies that focus on precision and minimally-invasive therapeutic solutions for the nervous system. Their closed-loop platform allows for high-resolution spinal cord stimulation, peripheral nerve stimulation, and brain-computer interfaces. The company has pioneered the development of Smart Programmable Electrodes, which feature a low-profile design and a high channel count, enabling efficient communication with the nervous system using fewer wires than traditional devices. This innovative approach is complemented by their proprietary electronic chips that facilitate the read-write signals necessary for effective neuromodulation.

Additionally, Micro-Leads Medical has made significant strides in injectable percutaneous technologies, particularly with their shape-memory electrodes that expand upon delivery, allowing for a broader therapeutic area while maintaining a minimally-invasive profile. Their self-expanding electrodes can be compressed into a catheter for easy insertion and then re-expand in dense tissues, providing targeted treatment for various nerve types. The company also emphasizes closed-loop neural sensing and stimulation, featuring advanced ASICs for high-voltage multiplexing and programmable stimulation, all of which can be controlled via Bluetooth technology for enhanced patient and clinician interaction.

United States

Micro-Leads is a medical device technology company developing injectable and laparoscopic, surgery-free devices for precision neurostimulation.  Micro-Leads closed-loop platform reads the body's physiological response to stimulation and writes an adaptive stimulation therapy.

Micro-Leads Medical

Company Details